Generic Name and Formulations:
Prazosin HCl 1mg, 2mg, 5mg; caps.
Indications for MINIPRESS:
Give 1st dose at bedtime. 1mg 2–3 times daily. Increase dose slowly. Usual dose: 6–15mg/day in divided doses; max 20–40mg/day. When adding another antihypertensive, reduce dose to 1–2mg 3 times daily and retitrate.
Syncope. Pregnancy (Cat.C). Nursing mothers.
Limit alcohol intake. Hypotension with propranolol, diuretics, other antihypertensives. False (+) pheochromocytoma test.
Syncope (esp. 1st dose), dizziness, headache, drowsiness, weakness, palpitations, GI upset, edema, orthostatic hypotension, dyspnea, vertigo, depression, nervousness, rash, urinary frequency, blurred vision, reddened sclera, epistaxis, dry mouth, nasal congestion; priapism (rare).
Caps 1mg, 2mg—250, 1000
Caps 5mg—250, 500
Clinical Pain Advisor Articles
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Optimal Strategies for Opioid Weaning After Ambulatory Surgery
- Emergency Physicians Offer Recommendations for Identifying and Managing Opioid Use Disorder
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness